DSM-Firmenich AG (DSMFF)
DSM-Firmenich AG (DSMFF) Stock Price, Analysis & Data
No data available
| Bid | n/a |
| Market Cap | 26.62B |
| Revenue (ttm) | 9.05B |
| Net Income (ttm) | 324M |
| Beta | 0.56 |
| EPS (ttm) | 1.61 |
| PE Ratio (ttm) | 67.08 |
| Forward PE | n/a |
| P/B (ttm) | 1.31 |
| P/S (ttm) | 2.94 |
| Earnings Date | Feb 18, 2027 |
| Ask | n/a |
| Volume | 800 |
| Avg. Volume (20D) | 1,021 |
| Open | 108.00 |
| Previous Close | 108.00 |
| Day's Range | 108.00 - 108.00 |
| 52-Week Range | 67.00 - 108.00 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $2.91 (2.7%) |
| Ex-Dividend Date | May 11, 2026 |
About DSMFF
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food ...
Financial Performance
In 2025, DSM-Firmenich's revenue was 9.03B, a decrease of -0.22% compared to the previous year's 9.05B. Earnings were -1.08B, a decrease of -532.4%.
Financial StatementsAnalysts project revenue of ... Upgrade
3 months ago · Simply Wall St.
DSM-Firmenich Medisca Deal Highlights U.S. Vitamin API And Valuation UpsideDSM-Firmenich (ENXTAM:DSFIR) has partnered with Medisca to expand access to pharmaceutical-grade vitamin active pharmaceutical ingredients in the U.S. market. The agreement focuses on supplying Europe...